Announcement PDF ASX Announcement 5 November 2024 Annual General Meeting Webinar SYDNEY Australia, 5 November 2024 – Atomo Diagnostics Limited (ASX: AT1) (Atomo or the Company) advises that the Annual General Meeting will be streamed live and shareholders are invited to join the Annual General Meeting live stream webinar (“Webinar”) on Friday, 15 November 2024 at 10:00am (AEDT). This Webinar is able to be viewed live via Microsoft Teams and will provide viewers the opportunity to hear from the Board and Executives of the Company. For the avoidance of doubt, the Webinar is a live stream of the event and does not give an opportunity to ask questions or submit votes. To register in advance for this Webinar, please follow this link: https://events.teams.microsoft.com/event/7b1c56fc-852a-4671-bba5-22d92c2b1068@89abb53e606b-4a58-88cf-1d132ad5aa57 After registering, you will receive a confirmation email containing information about joining the webinar. ~ ENDS ~ For more information, please contact: John Kelly Managing Director & CEO e. john.kelly@atomodiagnostics.com p. +61 401 922 279 Investor Queries investorqueries@atomodiagnostics.com This announcement was authorised by the Managing Director & CEO on behalf of the Board. About Atomo Atomo is an Australian-headquartered medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Atomo’s unique patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has successfully commercialised a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases including COVID-19, HIV, viral vs bacterial differentiation and female health. See more at www.atomodiagnostics.com Atomo Diagnostics Limited ACN 142 925 684 Level 1, 3-5 George St Leichhardt NSW 2040